Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational Results available

A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Conditional Labeling

ClinicalTrials.gov ID: NCT03884231

Public ClinicalTrials.gov record NCT03884231. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 7:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The Infinity MRI PMCF was conducted as an international, multicenter, observational, prospective, single-arm, post-market clinical follow-up (PMCF) study. The study evaluated the safety of the Infinity DBS system with MR Conditional labeling when an MRI procedure was performed according to the approved guidance. Subjects were followed for 1 month after the MRI procedure. Participation in the clinical study ended at the conclusion of the 1-month follow-up visit where subjects were then followed per standard of care.

Study identification

NCT ID
NCT03884231
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Abbott Medical Devices
Industry
Enrollment
74 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 9, 2019
Primary completion
Jul 21, 2021
Completion
Aug 19, 2021
Last update posted
Nov 19, 2024

2019 – 2021

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Banner University Medical Center Tucson Campus Tucson Arizona 85724
University of Colorado Hospital Aurora Colorado 80045
Neurosurgery One Littleton Colorado 80122
Emory University Hospital Atlanta Georgia 30322
Willis-Knighton Medical Center Shreveport Louisiana 71103
Robert Wood Johnson University Hospital New Brunswick New Jersey 08901
Wright State University & Premier Health Fairborn Ohio 45324
Inova Fairfax Hospital Falls Church Virginia 22042
Inland Northwest Research Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03884231, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 19, 2024 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03884231 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →